GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AcouSort AB (OSTO:ACOU) » Definitions » Cash-to-Debt

AcouSort AB (OSTO:ACOU) Cash-to-Debt : No Debt (1) (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is AcouSort AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. AcouSort AB's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, AcouSort AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for AcouSort AB's Cash-to-Debt or its related term are showing as below:

OSTO:ACOU' s Cash-to-Debt Range Over the Past 10 Years
Min: 4.35   Med: No Debt   Max: No Debt
Current: No Debt

During the past 11 years, AcouSort AB's highest Cash to Debt Ratio was No Debt. The lowest was 4.35. And the median was No Debt.

OSTO:ACOU's Cash-to-Debt is ranked better than
99.8% of 1486 companies
in the Biotechnology industry
Industry Median: 6.9 vs OSTO:ACOU: No Debt

AcouSort AB Cash-to-Debt Historical Data

The historical data trend for AcouSort AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

AcouSort AB Cash-to-Debt Chart

AcouSort AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

AcouSort AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison of AcouSort AB's Cash-to-Debt

For the Biotechnology subindustry, AcouSort AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AcouSort AB's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AcouSort AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where AcouSort AB's Cash-to-Debt falls into.



AcouSort AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

AcouSort AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

AcouSort AB had no debt (1).

AcouSort AB's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

AcouSort AB had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AcouSort AB  (OSTO:ACOU) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


AcouSort AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of AcouSort AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


AcouSort AB (OSTO:ACOU) Business Description

Traded in Other Exchanges
Address
Medicon Village, Lund, SWE, SE-223 81
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.

AcouSort AB (OSTO:ACOU) Headlines

No Headlines